Cardinal Health Inc
NYSE:CAH
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
93.74
125.33
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CAH stock under the Base Case scenario is 275.66 USD. Compared to the current market price of 123.27 USD, Cardinal Health Inc is Undervalued by 55%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Cardinal Health Inc
Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
Historical valuation for CAH cannot be conducted due to limitations such as insufficient data or other constraints.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Cardinal Health Inc
Balance Sheet Decomposition
Cardinal Health Inc
Current Assets | 32.9B |
Cash & Short-Term Investments | 2.9B |
Receivables | 11.8B |
Other Current Assets | 18.3B |
Non-Current Assets | 10.2B |
PP&E | 2.5B |
Intangibles | 6.4B |
Other Non-Current Assets | 1.2B |
Current Liabilities | 34.7B |
Accounts Payable | 30.4B |
Accrued Liabilities | 3.4B |
Other Current Liabilities | 940m |
Non-Current Liabilities | 11.7B |
Long-Term Debt | 4.2B |
Other Non-Current Liabilities | 7.4B |
Earnings Waterfall
Cardinal Health Inc
Revenue
|
224.3B
USD
|
Cost of Revenue
|
-216.8B
USD
|
Gross Profit
|
7.5B
USD
|
Operating Expenses
|
-5.3B
USD
|
Operating Income
|
2.2B
USD
|
Other Expenses
|
-937m
USD
|
Net Income
|
1.3B
USD
|
Free Cash Flow Analysis
Cardinal Health Inc
USD | |
Free Cash Flow | USD |
CAH Profitability Score
Profitability Due Diligence
Cardinal Health Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Score
Cardinal Health Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
CAH Solvency Score
Solvency Due Diligence
Cardinal Health Inc's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Score
Cardinal Health Inc's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CAH Price Targets Summary
Cardinal Health Inc
According to Wall Street analysts, the average 1-year price target for CAH is 129.69 USD with a low forecast of 102.01 USD and a high forecast of 152.25 USD.
Dividends
Current shareholder yield for CAH is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
CAH Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 47,300 full-time employees. The firm operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources and distributes a range of medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. This segment also distributes a range of national brand products and provides supply chain services and solutions to hospitals and other healthcare providers.
Contact
IPO
Employees
Officers
The intrinsic value of one CAH stock under the Base Case scenario is 275.66 USD.
Compared to the current market price of 123.27 USD, Cardinal Health Inc is Undervalued by 55%.